Glimisave MV 2.2F Tablet SR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (2mg) + Metformin (1000mg) + Voglibose (0.2mg)
Overview Glimisave MV 2.2F Tablet SR
Diabex Duo 2.2F Extended-Release Tablets are antidiabetic medications, a combination therapy for adult type 2 diabetes. They help manage blood glucose. Administer Diabex Duo 2.2F ER Tablets with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication even with controlled blood sugar; abrupt cessation without medical consultation risks elevated glucose, potentially causing kidney impairment, vision loss, neuropathy, and limb complications. This medication is part of a comprehensive program including diet, exercise, and weight management as directed by your doctor; lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect. Learn hypoglycemia symptoms (sweating, dizziness, headache, tremor) and management. Regular meals and readily available glucose sources (sugary foods, fruit juice) are essential. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any heart history before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your doctor, are necessary.
Primary Ingredients of Glimisave MV 2.2F Tablet SR
The provided text is "undefined," so there is nothing to rephrase.
Uses of Glimisave MV 2.2F Tablet SR
Managing type 2 diabetes
Major Benefits of Glimisave MV 2.2F Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimisave MV 2.2F Tablet SR should be administered on an empty stomach.
Common Side effects of Glimisave MV 2.2F Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimisave MV 2.2F Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisave MV 2.2F Tablet SR on an empty stomach.
How Glimisave MV 2.2F Tablet SR works:
The extended-release Glimisave MV 2.2F tablet combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisave MV 2.2F Tablet SR and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimisave MV 2.2F Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimisave MV 2.2F Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimisave MV 2.2F Tablet SR carries a high risk for individuals with kidney impairment and should be strictly avoided. Patients with severe kidney disease are strongly advised against its use. Medical consultation is recommended.
LiverCAUTION
Exercise caution when prescribing Glimisave MV 2.2F Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate Glimisave MV 2.2F Tablet SR therapy at a reduced dosage; its administration is contraindicated in cases of severe liver disease.
What if you forget to take Glimisave MV 2.2F Tablet SR :
Should you forget a dose of Glimisave MV 2.2F Tablet SR, take it promptly. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimisave MV 2.2F Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |





